After performing a multi-center study on 252 meningioma cases (119, 88, and 45 WHO grade I, II, and III cases, respectively), Sahm et al. concluded that TERT promoter mutations could be helpful in meningioma grading and causes increased meningioma grades and early recurrences [21]. The gene discussed is TERT; the disease is meningioma.